内皮
一氧化氮
内科学
平衡
医学
血压
药理学
生物
一氧化氮合酶
作者
Gaurav Kumar,Sanjay Kumar Dey,Suman Kundu
出处
期刊:Life Sciences
[Elsevier]
日期:2020-09-06
卷期号:259: 118377-118377
被引量:31
标识
DOI:10.1016/j.lfs.2020.118377
摘要
The endothelium is the innermost vascular lining performing significant roles all over the human body while maintaining the blood pressure at physiological levels. Malfunction of endothelium is thus recognized as a biomarker linked with many vascular diseases including but not limited to atherosclerosis, hypertension and thrombosis. Alternatively, prevention of endothelial malfunctioning or regulating the functions of its associated physiological partners like endothelial nitric oxide synthase can prevent the associated vascular disorders which account for the highest death toll worldwide. While many anti-hypertensive drugs are available commercially, a comprehensive description of the key physiological roles of the endothelium and its regulation by endothelial nitric oxide synthase or vice versa is the need of the hour to understand its contribution in vascular homeostasis. This, in turn, will help in designing new therapeutics targeting endothelial nitric oxide synthase or its interacting partners present in the cellular pool. This review describes the central role of vascular endothelium in the regulation of endothelial nitric oxide synthase while outlining the emerging drug targets present in the vasculature with potential to treat vascular disorders including hypertension.
科研通智能强力驱动
Strongly Powered by AbleSci AI